article thumbnail

California’s low-cost insulin plans receive $100m manufacturing boost

Pharmaceutical Technology

Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. In-house manufacturing the norm.

Insulin 328
article thumbnail

Incannex partners with Catalent to manufacture psilocybin

Pharmaceutical Technology

Incannex Healthcare has collaborated with New Jersey-based pharma company Catalent for the development and manufacturing of a cGMP-grade psilocybin drug product for clinical trials and potential commercial use. It will also establish cGMP manufacturing of a drug product which will be utilised in future clinical trials.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Eczac?ba?? to acquire Turkish pharma company Gensenta for $135m

Pharmaceutical Technology

Gensenta is a major manufacturer of finished pharmaceuticals and active ingredients in Turkey and is the key producer and exporter of lyophilized vials in the region. In addition, the company produces penicillin, Etodolac and various other active ingredients at its pharmaceutical ingredient manufacturing plant. The post Eczac?ba??

article thumbnail

Samsung Biologics and European pharma company enter major manufacturing deal

BioPharma Reporter

The global CDMO has entered into several high-value manufacturing deals this year.

article thumbnail

Samsung Biologics and European pharma company enter major manufacturing deal

BioPharma Reporter

The global CDMO has entered into several high-value manufacturing deals this year.

article thumbnail

Opinion: STAT+: Continuous manufacturing can help pharma companies save time, money, and more

STAT News

I’m talking about continuous manufacturing. Continuous manufacturing produces a drug product from start to finish through a nonstop, integrated assembly.

article thumbnail

Invest now to reduce manufacturing harms to environment, says pharma survey

Pharmaceutical Technology

The report, Pharmaceutical Manufacturing ESG Survey – Towards a Sustainable Supply Chain (November 2022), reveals that most pharma industry insiders believe the sector is not doing enough to limit harm to the environment. This is a particular problem for highly potent drugs such as antibiotics.